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Abstract
Prolonged inactivity induces muscle loss due to an activation of proteolysis and decreased protein synthesis; the
latter is also involved in the recovery of muscle mass. The aim of the present work was to explore the evolution of
muscle mass and protein metabolism during immobilization and recovery and assess the effect of a nutritional
strategy for counteracting muscle loss and facilitating recovery. Adult rats (6–8 months) were subjected to unilateral
hindlimb casting for 8 days (I0–I8) and then permitted to recover for 10 to 40 days (R10–R40). They were fed a
Control or Experimental diet supplemented with antioxidants/polyphenols (AOX) (I0 to I8), AOX and leucine (AOX +
LEU) (I8 to R15) and LEU alone (R15 to R40). Muscle mass, absolute protein synthesis rate and proteasome
activities were measured in gastrocnemius muscle in casted and non-casted legs in post prandial (PP) and post
absorptive (PA) states at each time point. Immobilized gastrocnemius protein content was similarly reduced (-37%) in
both diets compared to the non-casted leg. Muscle mass recovery was accelerated by the AOX and LEU
supplementation (+6% AOX+LEU vs. Control, P<0.05 at R40) due to a higher protein synthesis both in PA and PP
states (+23% and 31% respectively, Experimental vs. Control diets, P<0.05, R40) without difference in trypsin- and
chymotrypsin-like activities between diets. Thus, this nutritional supplementation accelerated the recovery of muscle
mass via a stimulation of protein synthesis throughout the entire day (in the PP and PA states) and could be a
promising strategy to be tested during recovery from bed rest in humans.
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Introduction
Prolonged inactivity or bed rest results in muscle wasting and
in an overall loss of lean body mass (see 1 for review). Besides
the obvious decreased physical performances, a reduced
muscle mass impairs defences since muscle is the most
important store of body amino acids (AA) useable during
environmental stresses. Thus, prevention of muscle loss during
the immobilization period and/or a stimulation or acceleration of
muscle recovery after immobilization is important to preserve
an optimum health status. This is especially important since
muscle inactivity is often associated with diseases/
physiological states, such as head injuries, sepsis or ageing
[2,3]. Resistance exercise is highly efficient to prevent muscle
protein loss during immobilization [4], however, exercise is not
always relevant in specific physio-pathological situations such
as invalidating diseases, joint pain or in frail elderlies. Thus, a
main clinical issue in such catabolic situations is the
development of new approaches to limit muscle atrophy and/or
improve subsequent recovery. These new strategies could also
be considered together with exercise when this later is feasible.
The loss of muscle mass during disuse is the result of an
imbalance between muscle protein synthesis and breakdown
[1,5]. During immobilization, an increased activation of
proteolytic systems has been well described in animals and
humans (involvement of ATP-Ubiquitin proteasome pathway
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[6-9], calpain system [6,10], lysosomal pathway [6]) associated
with a decreased protein synthesis in skeletal muscles [11-13].
The generation of an oxidative stress with an increased
production of reactive oxygen species (ROS) during the
immobilization period has been suspected to be partially
responsible of these muscle protein metabolism alterations in
both humans [14,15] and animals [16-19]. The prevention of
ROS production by mitochondrial-targeted molecules or dietary
antioxidants has been proven efficient in some studies to
preserve muscle mass during the immobilization period [16] or
at the beginning of the recovery period [20] via a reduction of
proteases activities and an inhibition of apoptosis. The
presence of an inflammatory state during immobilization [19]
and an associated resistance of muscle metabolism to anabolic
stimuli such as insulin [21] has also been clearly stated.
The experimental model of immobilization also directly
induces a resistance of muscle protein synthesis to anabolic
stimuli such as food intake and more precisely dietary proteins
and AA [22-24]. Because proteins and AAs are robust
stimulators of protein synthesis, AAs supplementation has
been tested to increase muscle anabolism during prolonged
immobilization. A particular attention was given to the branched
chain AA (BCAA) (leucine + valine + isoleucine) or more
precisely to leucine alone, which is known to stimulate muscle
protein anabolism. In bed rest studies, BCAA, leucine alone or
protein supplementation led to conflicting results with no impact
[25] or a positive effect [26,27] on protein synthesis and muscle
function. These results suggested that depending on the
degree of the muscle anabolic resistance to AA during the
immobilization period, leucine or AA supplementations may be
inefficient to prevent muscle mass loss. Indeed, in humans,
immobilization periods are often associated with pathology/
physiological states linked with an increase of stress mediators
(such as glucocorticoids [28]). Rieu et al (2004) have shown
that exogenous glucocorticoids induced a total resistance of
muscle protein synthesis to the anabolic effect of leucine which
rendered skeletal muscle response insensitive to amino acids
even at very high plasma concentration. In addition, it has been
shown that increased oxidative stress also reduced the ability
of amino acids (and leucine in particular) to stimulate muscle
protein synthesis [29].
To allow muscle recovery, it is necessary not only to
normalize the muscle protein synthesis / proteolysis ratio but
also to be in a situation of a positive nitrogen balance. It is now
well established that skeletal muscle proteolysis is normalized
very rapidly during the first days of reloading [6,7,19]. Then, a
stimulation of protein synthesis during the recovery period is a
major determinant of the muscle mass recovery. Because
sensitivity of muscle protein synthesis to anabolic stimuli
should progressively recover during reloading, leucine
supplementation may efficiently favor muscle anabolism during
this period. To our knowledge, and except for [25], free leucine
supplementation alone has not been tested yet during the
recovery period to accelerate muscle recovery in adults.
The aims of the present study are to assess the beneficial
effects of a sequential nutritional strategy to counteract muscle
loss and sustain/stimulate muscle protein anabolism during
immobilization and subsequent recovery in a rat model. The
sequential nutritional intervention consists in a dietary
supplementation of a mixture of antioxidants during the
immobilization period and the first phase of reloading (i.e.,
when an oxidative stress occurs and proteolysis stimulated)
combined with a supplementation of leucine during the
recovery period (i.e., when protein synthesis stimulation is
essential and most efficient for an optimal protein anabolism).
To our knowledge, no study has tested the combined and
sequential beneficial impact of a supplementation of leucine
and antioxidants on muscle protein mass and synthesis rates in
immobilized adult rats.
Materials and Methods
Animals and experimental design
This study was conducted in accordance with institutional
guidelines on animal experimentation in France and validated
by the Ethics Committee in Animal Experiment
CEMEAAuvergne (registration number: CE4-09). Male Wistar
rats aged 6-8 months were housed individually under controlled
environmental conditions (room temperature 22°C; 12 h light-
dark cycle, light period starting at 08:00 AM), fed ad libitum a
standard 13% casein diet (Table 1) and given free access to
water.
After a 3-week adaptation period with a standard diet (Table
1), 265 rats were anesthetized with isoflurane inhalation and
subjected to unilateral hindlimb cast immobilization with an
Orfit-soft plaque (Gibaud, France) for 8 days (I8). The foot was
positioned in plantar extension to induce maximal atrophy of
the gastrocnemius muscle [7,19,30,31]. On day I8, casts were
removed and animals were allowed to recover for 10 (R10), 15
(R15), 20 (R20), 30 (R30) or 40 (R40) days. The immobilized
animals were split in 2 groups and fed one of the two
experimental diets (Table 1, Figure 1). 133 immobilized rats
(EXPERIMENTAL group) were fed the standard 13% casein +
antioxidant (AOX) during immobilization, the diet was then
switched to a 13% casein + antioxidants + 4.45% leucine (AOX
+LEU) diet for the first 15 days of recovery (Figure 1) and
switched to a 13% casein + 4.45% leucine diet (LEU) for the
rest of the recovery period (from R15 to R40). The other 132
animals were fed a 13% casein diet (standard diet) during
immobilization and the same diet supplemented with alanine
(ALA) during the recovery; they constituted the control diet
group (Figure 1). The LEU and AOX+LEU diets were
supplemented with leucine to increase plasma leucine
concentration. the LEU and AOX+LEU diets were also
supplemented with appropriate amounts of valine and
isoleucine to prevent the fall in their concentration induced by
leucine supplementation [32]. Alanine, an amino acid which
has no effect on muscle protein metabolism, was included in
the standard diet (ALA) to normalize the quantity of AA given to
the animals during the recovery period in the control diet group.
Casted rats reduced their food intake during the
immobilization period (from 22 g to 15 grams). Therefore,
another group of 120 control non-casted rats were pair-fed to
the casted rats and were fed the same diets as the ones used
for the control diet group (i.e. standard diet during
immobilization and ALA diet during the recovery period) (Table
Leucine, Antioxidants and Muscle Recovery
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1, Figure 1). 24 rats were studied as a reference point before
the immobilization period (I0).
Before immobilization (I0) and at the end of the
immobilization period (I8) or at different time points during the
recovery period (R10, R15, R20, R30, R40) (n=16 /diet/time
point), animals were euthanized under pentobarbital sodium
anaesthesia (50 mg/kg ip). The evening of the day before each
time point studied, and for each diet, the food of half of the rats
in each group was withdrawn, so that the rats were in a post
absorptive state (PA) on the day of experiment. On the same
day, the other half was fed 6 grams of their respective diet and
ate all their given food in the following hour; these animals
Table 1. Composition of the standard and the experimental
diets.
 Control diet Experimental diet
 
Casein
standard diet ALA AOX AOX+LEU LEU
Ingredients
(g/kg dry
matter)
     
Casein 166 166 166 166 166
L cystine 1.8 1.8 1.8 1.8 1.8
Alaninea - 59 - - -
Leucine - - - 44.5 44.5
Valineb - - - 5.1 5.1
Isoleucineb - - - 9.8 9.8
Hesperetine 7
glucoside - - 1 1 -
Curcumin - - 1.43 1.43 -
Green tea
catechins - - 2 2 -
Rutin - - 2 2 -
Rapeseed oil 30 30 30 30 30
Sunflower oil 3 3 3 3 3
Peanut oil 27 27 27 27 27
Cellulose 35 35 28.57 28.57 35
Saccharose 100 100 100 100 100
Lactose 134 134 134 134 134
Wheat flour 458.2 399.2 458.2 398.8 398.8
Mineral
mixture
Control
35 35 - - 35
Vitamin
mixture
Control
10 10 - - 10
Mineral
mixture
supplemented
- - 35 35 -
Vitamin
mixture
supplemented
- - 10 10 -
Given during Adaptation
(1)
immobilization2 Recovery immobilization
Recovery
I8-R15
Recovery
R15-R40
Given to All rats 1 Pairfed rats 2
Pair fed
rats Casted rats
Casted
rats
Casted
rats
were then in the postprandial state (PP). Non-casted pair-fed
rats were also studied at the PA and the PP states using the
same procedure.
Measurements of in vivo protein synthesis
Protein synthesis rates were measured using the flooding-
dose method as previously described [33]. Each rat was
injected intravenously with [1-13C] valine (99%) (150
µmoles/100 g body), 40 min before euthanasia to flood the
precursor pool with [1-13C] valine. Rats were then euthanized
under pentobarbital sodium anaesthesia (50 mg/kg ip). Blood
was withdrawn from the aorta, and hindlimb gastrocnemius and
tibialis anterior muscles were carefully dissected, weighed and
frozen in liquid nitrogen. Gastrocnemius muscle was chosen for
protein synthesis assay because of its fibre type composition
(mixed) and its size allowing multiple assays once milled.
Free and bound valine enrichments were determined as
follows. Muscles were powdered in liquid nitrogen in a ball mill
(Dangoumeau, Prolabo, Paris, France). A 200 mg-aliquot of
frozen muscle powder was homogenized in 2 mL of 10%
trichloroacetic acid (TCA). Homogenates were centrifuged
(8000 rpm, 15 min, 4°C) and supernatants, containing free
amino acids, were desalted by cation-exchange
chromotography (AG 50 x 8, 100–200 mesh, H+ form, Bio-Rad,
Richmond, CA) in minidisposal columns. Valine and other
amino acids were eluted with 4 mol/L NH4OH. After
evaporation of NH4OH under vacuum, free amino acids were
resuspended in 0.01 mol/L HCl for enrichment measurements.
TCA-insoluble materials were washed in 4 volumes of cold
Table 1 (continued).
Diets were provided by INRA (Unité de Préparation des Aliments Expérimentaux,
Domaine de Vilvert, Jouy-en-Josas, France)
Vitamin mix control expressed (/kg mix) : Nicotinic acid 3g, D-Pantothenate Ca 1.6
g, Pyridoxine HCl 0.7g, Thiamin HCl 0.6, Riboflavin 0.6 g, Folic acid 0.2 g, D-Biotin
0.02 g, Vitamin B12 (0.1%) 2.5 g, Vitamin K 0.075 g, Choline (chlorhydrate,
bitartrate) 250 g, Vitamin E 1000 IU, Vitamin A 400000 IU, Vitamin D3 100000 IU.
Vitamin mix supplemented: similar to vitamin mixture control except for Vitamin E:
30000 IU and Vitamin A: 800000 IU
Mineral mix control expressed in (mg/kg mix): Calcium carbonate 357, Potassium
phosphate, monobasic 250, Sodium chloride 74, Potassium sulfate 46.6,
Potassium citrate monohydrate 28, Magnesium oxide 24, Ferric citrate 6.06, Zinc
carbonate 1.65, Manganous carbonate 0.63, Curpic carbonate 0.3, Potassium
iodate 0.01, Sodium selenate anhydrous 0.01025, Ammonium paramolybdate, 4
hydrate 0.00795, Sodium meta-silicate, 9 hydrate 1.45, Chromium potassium
sulfate, 12 hydrate 0.275, Boric acid 0.0815, Sodium fluoride 0.0635, Nickel
carbonate 0.0318, Lithium chloride 0.0174, Ammonium vanadate 0.0066.
Mineral mix Supplemented: similar to Mineral mix control except for Zinc carbonate
2.73 and Sodium selenate anhydrous 0.1429.
The standard diet was used for the adaptation period for all rats (1) and for the
immobilization period in pair fed rats only (2)
a Alanine was included in the +ALA diet to render the diets isonitrogenous. This
amino acid has no effect on muscle protein metabolism; b Valine and isoleucine
were included in the +AOX+LEU and the +LEU diet to prevent the fall of their
plasma concentrations induced by leucine supplementation.
doi: 10.1371/journal.pone.0081495.t001
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10% TCA and 3 times in 4 volumes of 0.2 mol/L perchloric acid
(PCA). Resultant pellets were resuspended in 0.3 mol/L NaOH
and incubated at 37°C for 1 h. Protein concentration was
determined using the bicinchoninic procedure [34]. Proteins
were precipitated with 20% PCA overnight at 4°C, samples
centrifuged (10,000 x g, 5 min, 4°C). The protein pellet was
hydrolyzed in 6 mol/L HCl at 110°C for 24 h. HCl was removed
by evaporation and amino acids purified by cation-exchange
chromotography as described above. Measurement of free
valine enrichment was done as its t-butyldimethylsilyl derivative
by gas chromatography electron impact mass spectrometry,
using a gas chromatograph coupled to an organic mass
spectrometer quadrupole (GC-MS Hewlett-Packard 5971A,
Hewlett-Packard Co., Palo Alto, CC=A, USA). Enrichment of
[1-13C] valine into muscle proteins was measured as its N-
acetyl-propyl derivatives by gas chromatography–combustion-
isotope ratio mass spectrometry (Isoprime, Cheadle, UK).
Calculations
The absolute synthesis rate (ASR) was calculated from the
product of the protein fractional synthesis rate (FSR) and the
protein content of the tissue and expressed in mg/d. FSR (in
%/d) is calculated from the formula : FSR = Sb x 100/Sa x t,
were Sb is the enrichment at time t (minus natural basal
enrichment of protein from gastrocnemius taken from rats not
submitted to labelled valine injection) of the protein-bound
valine, t is the incorporation time in d, and Sa is the mean
enrichment of free tissues valine between time 0 and t
according to [33]. The mean Sa enrichment was the Sa (t1/2)
value calculated from the linear regression obtained in tissue
between time 0 and time t.
Plasma amino acid measurements
Plasma amino acid concentrations were determined for each
group at selected time-points I0, I8, R15 and R40. Plasma
amino acids were purified, i.e., 500 µL of plasma was added to
125 µL of sulfosalicylic acid solution (1 mol/L in ethanol with 0.5
mol/L thiodiglycol) previously completely evaporated.
Norleucine was added as an internal standard. Amino acid
concentrations were determined using an automated amino
acid analyzer with BTC 2410 resin (Biotronic LC 3000,
Roucaire, Velizy, France).
Inflammatory and oxidative markers in plasma and
gastrocnemius muscle
To assess chronic inflammation, fibrinogen concentration in
plasma was assessed, as previously described [35].
Inflammatory status in the gastrocnemius muscle was
evaluated by measuring muscle content of MCP-1, a cytokine
recruiting inflammatory cells. MCP-1 was detected using an
ELISA kit (RayBio Rat MCP-1 ELISA RayBiotech, Inc.,
Norcross, GA, USA) which uses an antibody specific for rat
MCP-1. The results were expressed as nanograms of MCP-1
per milligram of muscle. Oxidative status in the muscle was
evaluated by measuring gastrocnemius muscle content of the
total glutathione as previously described [36]. Results were
expressed as µmol per gram of gastrocnemius.
Measurement of chymotrypsin- and trypsin-like
activities of the proteasomes
Samples of gastrocnemius muscle powder (see above
“Measurements of in vivo protein synthesis”) were
homogenized in 10 vol of an ice-cold buffer (pH 7.5) [50
mmol/L Tris-HCl, 250 mmol/L sucrose, 10 mmol/L ATP, 5
Figure 1.  Study design used in the three groups of pair fed rats, immobilized control rats and immobilized antioxidants
and/or leucine supplemented rats.  
doi: 10.1371/journal.pone.0081495.g001
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mmol/L MgCl2, 1 mmol/L DTT, and proteinase inhibitors (10
µg/mL antipain, 10 µg/mL leupeptin, 10 µg/mL pepstatin, 10
µg/mL aprotinin, and 0.2 mmol/L PMSF)] as previously
described (69,70). Briefly, extracts were centrifuged at 10,000 x
g for 20 min at 4°C. Supernatants were then centrifuged at
100,000 x g for 1 h at 4°C. The resulting supernatants were
finally centrifuged at 100,000 x g for 5 h at 4°C. The resulting
protein pellets were resuspended in 150 µL of a buffer
containing glycerol (20%), 50 mmol/L MgCl2, and 5 mmol/L
Tris·Cl, pH 7.5 (buffer B). Protein concentration was
determined on these resuspended pellets using the Bio-Rad
protein assay kit. The proteasome chymotrypsin- and trypsin-
like activities were determined by measuring the hydrolysis of
the fluorogenic substrates succinyl-Leu-Leu-Val-Tyr-7-amido-4-
methylcoumarin (LLVY-AMC), and succinyl-Leu-Arg-Arg-AMC
(LRR-AMC) (Enzo Life Sciences), respectively. Five microliters
(~15 µg proteins) of the resuspended pellets were diluted in 15
µL of buffer B and added to 60 µL of a reaction buffer [50
mmol/L Tris·Cl (pH 8), 11.25 mmol/L MgCl2, 1.25 mmol/L DTT,
and 0.01 U apyrase] containing either 300 µmol/L LLVYAMC or
800 µmol/L LRR-AMC to measure the proteasome
chymotrypsin-or trypsin-like activities, respectively. Pilot
experiments were performed with or without the proteasome
inhibitor (MG132, Enzo Life Sciences) at 40 or 100 µmol/L to
ensure full inhibition of chymotrypsin- or trypsin-like activities
respectively. Activities were determined by measuring the
accumulation of the fluorogenic cleavage product (AMC) using
a luminescence spectrometer FLX800 (Biotek) for 45 min at
380-nm excitation wavelength and 440-nm emission
wavelength. Then, the activities were determined by calculating
the difference between arbitrary fluorescence units recorded
with or without MG132 in the reaction medium. The final data
were corrected by the amount of protein. The time course for
the accumulation of AMC after hydrolysis of the substrate was
analyzed by linear regression to calculate activities, i.e., the
slopes of best fit of accumulation AMC vs. time.
Statistical analysis
The statistical analysis was done using a non-parametric
approach. Exact Wilcoxon Rank-Sum tests have been
performed for all the comparisons of interest using the software
R 2.14.1.
Significance was defined for P<0.05 level, tendency was
defined for P<0.1.
The Hodges Lehman estimator related to the Wilcoxon test
(which estimates the difference between the medians of the
two groups to be compared) was used to express all the
percentages of increase or decrease of one group relatively to
another group (Hodges Lehman estimate divided by the
median of the relative group [37]).
Each figure is a descriptive representation of the data, using
these two statistical indicators: Median and Standard Error of
the Median (SE-Median)
Results
Food intake and body weight changes
Before immobilization, food intake averaged 22g for all
animals. Immobilization led to a lower food intake in both
CONTROL and EXPERIMENTAL groups (13.5 ± 0.0 and 15.9
± 0.4 g, respectively, Figure 2A). Food intake progressively
increased throughout the recovery and reached a plateau
around 20-22 g from R15 onwards in both groups.
Body weight was reduced by 4.8% (regarding the median of
all the individual reductions) in the pair fed group and by 8.9%
and 9.4% in the two different casted groups at the end of the
immobilization period (Figure 2B). The animals’ weight
progressively increased in all groups during the recovery period
(Figure 2B) to reach the following values: 582.5±9.5, 594.5±8.5
and 596±12.7 for CONTROL, EXPERIMENTAL and pair fed
groups respectively (Figure 2) at the end of the recovery
period.
Plasma amino acid concentrations
Plasma levels in leucine were not affected by immobilization
in all groups (I8 vs I0, Table 2). During the recovery period,
leucine is added in the in the EXPERIMENTAL diet of
immobilized animals (Table 1), explaining the increased
plasma concentration in the EXPERIMENTAL animals at R15
and R40 (Table 2). Concomitantly, other BCAA were also
supplemented to avoid any decreased concentration in plasma
due to leucine supplementation which could have limited
protein synthesis. This can be shown by plasma isoleucine
concentrations where no decreased concentration was
observed in EXPERIMENTAL animals (Table 2).
In order to normalize the AA supply, alanine was
supplemented in Control immobilized and pair fed animals,
inducing a slight increase (+18.8%, at R40, P<0.1) of plasma
alanine concentration observed in control immobilized animals
relatively to immobilized supplemented (Table 2).
Muscle mass during immobilization and recovery
Immobilization induces a decrease in muscle mass (-32 and
-24%, between the immobilized and the pair fed muscle at I8
for Gastrocnemius and Tibialis anterior respectively) (Figure 3).
No difference between the EXPERIMENTAL vs CONTROL
groups on muscle mass could be recorded at the end of the
immobilization period (Figure 3). When expressed as a
percentage of the muscle mass at I8, muscle mass in all
immobilized muscles progressively increases during the
recovery period in all muscles in EXPERIMENTAL and
CONTROL relatively to the muscles of pair fed animals which
were not previously immobilized (Figure 3). The percentage of
recovery of muscle mass of the Gastrocnemius and Tibialis
anterior muscles from the EXPERIMENTAL group was
significantly (P<0.05) above the values from the CONTROL
group at R30 and R40, suggesting an accelerated recovery of
the muscle mass in the EXPERIMENTAL relatively to the
CONTROL group. Concerning the Gastrocnemius mass in the
non- immobilized leg (which could be also considered as an
internal reference value), no important difference between the
CONTROL and EXPERIMENTAL groups and the pair fed
Leucine, Antioxidants and Muscle Recovery
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group was observed (Figure 4) except for small differences at
R10 and R30.
Gastrocnemius muscle protein content was reduced by
37.1% and 36.7% between I0 and I8 in CONTROL and
EXPERIMENTAL animals respectively (P<0.001, I8 vs I0)
(Figure 5). A small reduction in Gastrocnemius protein mass
was also observed in pair fed animals (-8.6%, P<0.05, I8 vs I0,
Figure 5). A diet effect was observed during the recovery
period with a more rapid recovery of the gastrocnemius muscle
protein mass in the EXPERIMENTAL animals vs CONTROL:
protein mass was not different in EXPERIMENTAL animals vs
pair fed but significantly different between EXPERIMENTAL vs
CONTROL animals at R40 (P<0.05, Figure 5).
Effect of immobilization and recovery on protein
synthesis in the post prandial and post absorptive
states
Immobilization.  In the post absorptive state, whereas
absolute synthesis rate (ASR) remained stable throughout the
entire experimental period in the pair fed animals,
immobilization led to a similar decreased ASR in
gastrocnemius muscle whatever the diet considered (-48.7%
Figure 2.  Food intake (A) (g/day) and body weight (B) (g) of casted control, casted supplemented and non-casted pair fed
rats.  Values are median ± SE-Median.
doi: 10.1371/journal.pone.0081495.g002
Table 2. Plasma leucine, isoleucine and alanine concentrations in the post prandial state of rats.
 I0 I8 R15 R40
  Pair Fed
Immobilized
Control
Immobilized
Supplemented Pair Fed
Immobilized
Control
Immobilized
Supplemented Pair Fed
Immobilized
Control
Immobilized
Supplemented
Leucine 106±6 116±13 104±9 94±7 106±15 115±12 286±46* 105±7 118±10 251±19*
Isoleucine 54±4 65±7 56±6 51±5 58±8 70±7 61±13 53±4 62±4 56±5
Alanine 432±19 547±84 408±31 388±21 609±79 607±57 513±19† 502±69 555±22 455±38†
Amino acid concentrations are presented at the post prandial state before (I0) and after (I8) the immobilization period but also during the recovery period (R15 and R40; 15
and 40 days of recovery, i.e. after cast removal). Values expressed in µmol/L are median ± SE-Median. * P<0.05 † P<0.1 Immobilized Control vs Immobilized
Supplemented.
doi: 10.1371/journal.pone.0081495.t002
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and -39.1% between I0 and I8 for CONTROL and
EXPERIMENTAL animals respectively, P<0.001) (Figure 6A).
Similarly, in the post prandial state, a significant decreased
ASR was observed in immobilized leg in both diet groups
(-42.1% and -45.8% between I0 and I8 for CONTROL and
EXPERIMENTAL animals respectively, P<0.001) (Figure 6B).
ASR was also decreased between I0 and I8 (-16.6%, P<0.05)
(Figure 6B) in the pair fed group. No significant difference of
ASR in gastrocnemius was observed between CONTROL and
EXPERIMENTAL animals at I8.
Recovery.  In the post absorptive state, ASR in the
gastrocnemius muscle was similar between the three groups at
R10. From R15 to R40, ASR in gastrocnemius of
EXPERIMENTAL animals was above the values observed for
the CONTROL group and pair fed group. This difference
becomes significant at R40 (23.0% and 17.5% for
EXPERIMENTAL vs CONTROL and pair fed respectively,
P<0.05) (Figure 6A).
In the post prandial state, a similar trend was observed with
an ASR in gastrocnemius of EXPERIMENTAL animals above
the values observed for the CONTROL group and pair fed
group. At R10, ASR of proteins in gastrocnemius muscle of
EXPERIMETNAL group was significantly above the pair fed
group (+24.6%, P<0.05) (Figure 6B). The effect was also
present at R40 with a 31.3% and 28.3% increased ASR in
EXPERIMENTAL animals vs CONTROL and pair fed groups
respectively (P<0.05) (Figure 6B).
Effect of immobilization and recovery on trypsin-like
and chymotrypsin-like activities
Muscle protein mass is controlled by the balance between
rates of protein synthesis and breakdown. The proteasome
system (UPS) is involved in the breakdown of the major
contractile proteins in catabolic conditions, and we previously
reported that the activation of the UPS pending immobilization
was normalized 20 days after cast removal [7]. Thus, the
regulation of the UPS was assessed during immobilization (I8)
and recovery until R20 by measurements of the main peptidase
activities of the proteasomes, i.e. the chymotrypsin (CT)- and
the trypsin (T)-like.
The CT- and T-like activities of the proteasome were similar
in muscles from animals either in the post absorptive or the
post prandial state in all groups during the whole kinetic studied
(data not shown). Thus, data obtained in both the post
absorptive and the post prandial state were pooled and
analysed regarding the effect of the diet.
The CT- and the T-like activities of the proteasomes did not
change significantly in immobilized gastrocnemius of
EXPERIMENTAL or CONTROL animals compared to the pair
fed group (Figure 7). Only the CT-like activity of the
proteasome increased at I8 in immobilized gastrocnemius of
EXPERIMENTAL rats compared to the I0 group (+34.7%,
P<0.05, Figure 7A) and at R20 in remobilized gastrocnemius of
EXPERIMENTAL and CONTROL animals compared to the pair
fed group (+20.5 and 29.5%, respectively, P<0.05, Figure 7A).
Figure 3.  Muscle mass of the immobilized leg for casted control and casted supplemented rats and of one of the legs of
the non-casted pair fed rats.  The muscle mass in the 3 groups is presented at I8. The muscle mass during the recovery period is
expressed as a percent (%) of the weight of the muscle at the end of the immobilization period (ie I8 time point). A: Gastrocnemius,
B: Tibialis Anterior.
Values are median ± SE-Median. a,b,c significantly different (non-casted Pair-fed vs casted Control vs casted AOX± Leu) (P<0.05)
within each time point.
doi: 10.1371/journal.pone.0081495.g003
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Oxidative and inflammatory markers in the
gastrocnemius muscle
Immobilization induced an increased glutathione level in the
immobilized leg of the casted CONTROL and EXPERIMENTAL
animals relatively to the pair fed non immobilized group
(+26.1% and +40.8% vs pair fed at I8 for CONTROL and
EXPERIMENTAL animals respectively, P<0.05, Figure 8A). In
addition, the supplementation in antioxidants led to a more
elevated level of glutathione in the immobilized leg of the
EXPERIMENTAL animals vs CONTROL at I8 (+12.0% in
EXPERIMENTAL vs CONTROL, P<0.05, Figure 8A).
Glutathione concentrations in the immobilized animals
decreased at R10 and R15 and the values were not
significantly different between groups at those two time points.
No significant impact of the immobilization or diet interventions
could be observed in the controlateral leg (data not shown).
The monocyte chemotactic protein-1 (MCP-1) levels in the
immobilized leg were strongly increased by 166.8% and
115.1% vs pair fed (P<0.05) in the CONTROL and
EXPERIMENTAL animals respectively at I8 (Figure 8B). No
differences between the two experimental diets were observed
at I8 for MCP1. MCP1 content in muscles decreased in
immobilized legs at R10 and R15. Although still significantly
(P<0.05) above the values of pair fed animals, MCP1 values in
the immobilized animals normalized progressively between
immobilized animals and pair fed animals during the recovery
period.
Discussion
In the present study, we showed that a dietary
supplementation of adult rats undergoing 8 days of
immobilization followed by a recovery period with a mixture of
antioxidants during immobilization and leucine ± antioxidants
during the recovery period led to an accelerated recovery of
muscle mass. This dietary effect of leucine ± antioxidants was
related to a stimulation of muscle synthesis rate both in the
post prandial and the post absorptive states during the
recovery period. Indeed, whereas a muscle mass decrease of
about 25% was observed at the end of the immobilization
Figure 4.  Gastrocnemius muscle mass (g) of the non-casted leg of the immobilized control and supplemented rats and of
one of the legs of the non-casted pair fed rats.  Values are median ± SE-Median. a,b,c significantly different (non-casted Pair-fed
vs casted Control vs casted AOX± Leu) (P<0.05) within each time point.
doi: 10.1371/journal.pone.0081495.g004
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period with both diets, the muscle of immobilized control
animals was still 10% lower relatively to the non-immobilized
pair fed animals and no longer significantly different in the
leucine ± antioxidants animals. The extrapolation of such type
of accelerated recovery of muscle mass to various clinical
situations associated with bed rest and muscle atrophy may be
of primary importance in the convalescence of these patients.
This study also described the kinetics of modification of
muscle protein mass and metabolism following 8 days of
immobilization and during the recovery period. The kinetics and
mechanisms of decrease in muscle protein mass during
immobilization have been well described in various species
[7,19,22,26,38,39]. However, little was known on the
mechanisms stimulated during the recovery period with a few
data concerning the adaptation of proteolytic and apoptotic
pathways [7,25] and even less concerning protein synthesis
[25,40], particularly in vivo in both the post prandial and the
post absorptive states [40].
Protein synthesis involvement in the muscle protein
loss and recovery
Eight days of immobilization led to a drastic decreased
protein mass in the Gastrocnemius muscle (about -37%).
These data are consistent with those obtained with the same
immobilization model in adult [7] and old [19] rats and were the
consequence of an activation of the ubiquitin-proteasome
pathway [7,19,24] and also, as shown in the present study, to a
reduction of protein synthesis (both in the post-absorptive and
the post-prandial states). In the present study, our data suggest
a moderate activation of the UPS: only the chymotrypsin-like
activity of the proteasome increased in immobilized leg when
compared with the I0 group, but not with pair fed animals. We
Figure 5.  Gastrocnemius muscle total protein mass (mg) of the immobilized leg for casted control and casted
supplemented rats and of one of the legs of the non-casted pair fed rats.  Values are median ± SE-Median. a,b,c significantly
different (non-casted Pair-fed vs casted Control vs casted AOX± Leu) (P<0.05) within each time point.
doi: 10.1371/journal.pone.0081495.g005
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previously reported that the peptidase activities of the UPS
may be strongly [7] or moderately [20] enhanced, or
unchanged [41] from an experiment to another, probably
resulting from the intensity of muscle damages induced by
immobilization per se. The reduction of protein synthesis,
generally measured in the fasted state, has already been
observed in muscle of immobilized rats [30,42] or during bed
rest in humans [1,43,44]. The fact that protein synthesis was
decreased in both the post prandial and post absorptive states
in the present study explained the rapid and important muscle
loss observed after only 8 days of immobilization. Among the
potential mechanisms responsible for the muscle loss, the
decreased muscle protein synthesis in the post prandial state
showed that immobilization rendered the muscle less capable
to respond to anabolic stimuli such as meal intake or amino
acids supplementation, as observed by [23,45,46] and the
present study. A blunted response of the mTORC1 signalling
pathway as well as a reduction of AA transporters numbers is a
potential mechanism [45]. Conversely to the reduction of
protein synthesis observed after immobilization, during the
recovery we observed an activation of protein synthesis, which
was probably the most important mechanisms explaining the
protein gain since proteolysis inhibition was limited to the early
stages of recovery. Indeed, we [7] have shown in the same
animal model a normalization of the proteolytic systems
activities within the first 10 days of recovery (or at the latest
R15) and this could not explain the muscle protein mass gain
observed throughout the entire recovery period of 40 days
[7,19]. In our study, the stimulation of protein synthesis in both
the post prandial and post absorptive states during the
recovery period favoured the observed gain of muscle mass.
The resistant state to anabolic stimuli occurring during the
immobilization period (and the increased sensitivity during
recovery) can be multifactorial. An alteration of the oxidative
status within the immobilized gastrocnemius can be
hypothesized in the present study since the glutathione content
increased in the muscle at the end of the immobilization period.
The increased ROS in disuse may be implicated directly in the
stimulation of proteolysis and cell death via a modulation of the
MAPK pathway and an activation of the NFkB pathway, as
reviewed by [14]. To this direct effect, the presence of an
oxidative stress during immobilization (generation of ROS)
[16,19,47] has also recently been shown to be one of the
determinants of the presence of an insulin resistant state of
glucose transport at the muscle level (via a loss of IRS-1, p38
MAPK activation and PI-3K pathway activation) [48-50]. Both
Figure 6.  Muscle protein absolute synthesis rate (mg proteins synthesized/day) in the immobilized gastrocnemius muscle
of control casted and supplemented casted rats and in the gastrocmemius muscle of pair fed non-casted rats.  Protein
synthesis was measured both in the post absorptive (A) and in the post prandial (B) states.
Values are median ± SE-Median. a,b significantly different (non-casted Pair-fed vs casted Control vs casted AOX± Leu) (P<0.05)
within each time point.
doi: 10.1371/journal.pone.0081495.g006
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mechanisms of action of ROS could explain at least partially
the muscle loss observed during immobilization by both acting
on proteolytic systems (activation) and the protein synthesis
response (decreased) to the amino acids supplementation in
the meal [51].
Immobilization is also characterized by the presence of an
inflammatory state, particularly at the muscle level, as can also
be hypothesized in the present study with a significant
increased concentration of MCP-1 content in the muscle after
immobilization relatively to the non-immobilized pair fed
animals. Similar data were obtained by [19,52] and were
closely related to the presence of a resistant state to anabolic
stimuli such as insulin [21]. In addition, a differential response
of genes involved in inflammatory response and oxidative
stress to insulin has been recently demonstrated in young men
following bed rest [53].
The progressive normalization of the oxidative stress and
inflammatory status during the recovery period, as shown in the
present study with a normalization of the glutathione muscle
concentrations 15 days after cast removal, and MCP-1
normalization within 10 days can be some factors involved in
the improved muscle response to food intake during the
recovery period. It is probable that these normalization
processes were associated with the increased sensitivity of
protein metabolism to the effect of meal.
Impact of the supplemented diet on muscle protein loss
during immobilization
The supplemented diet did not help to prevent the muscle
mass loss during the immobilization period (muscle protein and
muscle mass losses were similar in both control and
supplemented immobilized leg), showing that the antioxidants
supplementation alone was not capable to limit the decrease in
protein synthesis both in the post prandial and post absorptive
states. The preservation of some components involved in the
muscle antioxidant status in the supplemented animals (i.e
glutathione in the present study) was not sufficient to preserve
muscle mass. Although the oxidative stress has been shown to
be potentially involved in the decreased sensitivity of muscle
metabolism to anabolic stimuli such as insulin or AA (as
detailed above), conflicting results emerge on the impact of
antioxidants supplementation on immobilized muscle during the
immobilization period. Antioxidants supplementation was
proven inefficient (mixture of antioxidants [54]; curcumin [20];
vitamin E [55]; resveratrol [56]) or capable (vitamin E [57,58],
resveratrol [59]) to counteract the catabolic impact of
immobilization on muscle mass. In our study, the antioxidants
supplementation was not sufficient (in terms of dose or
antioxidants used) to enhance the muscle response to anabolic
stimuli (such as insulin or AA). Similarly, immobilization is also
characterized by the presence of an inflammatory state, as
confirmed in the present study with a significant increased
concentration of MCP-1 content in the muscle after
Figure 7.  Peptidase activities of the proteasome in the immobilized gastrocnemius muscle of control casted and
supplemented casted rats and in the gastrocmemius muscle of pair fed non-casted rats.  The chymotrypsin-like (A) and the
trypsin-like activities (B) of the proteasome were measured using a fluorogenic substrate on partially purified proteasome extracts.
Data are expressed as Relative Fluorescent Unit (RFU)/µg protein/min.
Values are median ± SE-Median. *significantly different (non-casted Pair-fed vs casted Control vs casted AOX± Leu) (P<0.05) within
each time point.
doi: 10.1371/journal.pone.0081495.g007
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immobilization relatively to the non-immobilized pair fed
animals. Similar data were obtained by [19,52] and have been
closely related to the presence of a resistant state to anabolic
stimuli such as insulin [21]. In the present study, however, the
two experimental diets did not impact differently on MCP-1
content in the muscle at the end of the immobilization period,
suggesting that the antioxidants supplementation did not
impact significantly on the muscle inflammation status in our
rats.
Nutritional effect during the recovery period
Data concerning the nutritional supplementations potentially
capable to limit muscle mass loss during bed rest are
increasing in the literature as summarized by [60-62]. However,
very few studies have tackled the crucial issue of the recovery
period [24,61]. In our study, after cast removal, the
supplemented diet sped up the muscle mass recovery. This
was explained by an increased protein synthesis rate in
gastrocnemius of supplemented immobilized animals above
the values obtained in the control immobilized animals both in
the post prandial and the post absorptive states. This improved
stimulation of muscle protein synthesis could explain the strong
impact of the supplementation on the more rapid muscle
protein mass recovery. Changes in UPS proteolysis, as
assessed by measurement of peptidase activities of the
proteasome, did not seem to be involved in the acceleration in
the muscle mass recovery in supplemented animals. However,
a positive impact of the supplementation on the UPS proteolytic
system cannot be excluded. In fact, in this pathway the
substrate is first targeted by a poly-Ub chain, and the targeted
protein is then recognized and degraded by the 26S
proteasome [63]. In addition, we previously reported that the
UPS proteolysis was normalized with the first 15 days of
recovery [7,19,20]. Thus, a beneficial effect of the
supplementation may have improved UPS alterations at the
polyubiquitination level and may have occurred mainly during
this first phase of the recovery period. Finally, a beneficial
effect of leucine supplementation may prevail also on other
proteolytic systems, in particular the lysosomal pathway. In
fact, autophagy, which directed substrates to the lysosome, is
also important in the control of muscle mass [64] and is
regulated by leucine [65-67]. For example, leucine deprivation
increased autophagy in C2C12 muscle cells [65] and,
conversely, elevation of leucine intake in humans decreased
autophagy in muscle biopsies[67].
The supplementation during the recovery period consisted in
a mixture of antioxidants/polyphenols and leucine for the first
15 days of recovery and in leucine alone for the later recovery
period (from R15 to R40). Because antioxidants were
supplemented simultaneously with leucine at the beginning of
the recovery period, the beneficial effect of the nutritional
supplementation during that period could be attributed to the
supplementation in antioxidants mixture, leucine or the
Figure 8.  Glutathione (µmol/g muscle) (A) and Monocyte chemotactic protein-1 (MCP-1) (B) (pg/mg muscle) in the
immobilized gastrocnemius muscle of control casted and supplemented casted rats and in the gastrocmemius muscle of
pair fed non-casted rats.  Values are median ± SE-Median. a,b,c significantly different (non-casted Pair-fed vs casted Control vs
casted AOX± Leu) (P<0.05) within each time point.
doi: 10.1371/journal.pone.0081495.g008
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combination of both. It could be observed in the data from [19]
and [47] on proteolytic/apoptotic activities and indexes of
muscle oxidation response that both parameters were restored
in a similar manner during the recovery period. In addition,
curcumin supplementation in the diet of rats has been proven
efficient during the early phases of recovery by reducing the
increased Smac/DIABLO protein levels induced by
immobilization [20].
While the action of antioxidant/polyphenols on muscle mass
recovery remains to be more specifically studied, there is no
doubt on the fact that leucine supplementation had a specific
impact on muscle mass recovery in our study. The specific role
of leucine (relatively to the antioxidants supplied during the first
15 days of recovery) was clear since protein synthesis rates
were still more elevated in the muscle of the supplemented
group relatively to control at R40 (whereas antioxidant
supplementation was stopped at R15). Very few studies have
actually tackled the concept of AA supplementation during the
recovery period after bed rest and to our knowledge, only
[25,68,69] have shown an anabolic or small impact of essential
AA or branched chain AA on nitrogen retention or muscle mass
during the recovery period after immobilization. Our study
demonstrated for the first time an anabolic impact of leucine
supplementation on muscle mass of adult animals during the
recovery period via an activation of protein synthesis both in
the post prandial and post absorptive states. The beneficial role
of AA in the stimulation of muscle mass anabolism has been
studied in detail [70-73] with an activation of the muscle
anabolism post-prandially [74]. Among AA, leucine is known to
play a major role in the stimulation of protein synthesis [75,76]
and inhibition of proteolysis [77] in normal and catabolic states.
During immobilization, the anabolic resistance of muscle
protein metabolism to anabolic stimuli such as AA shown by
[23] can be counteracted by leucine alone, BCAA or protein
supplementation [26,78] but not always [68,79]. The response
of protein anabolism to the AA supplementation during bed-rest
depends tightly on the level of resistance of the metabolism
induced by immobilization, which explains the apparent
discrepancy in the anabolic potential of AA supplementation
during immobilization in various studies. The originality of our
results lies in the fact that AA supplementation (leucine in our
case) is done when the sensitivity of protein metabolism to AA
was increased (i.e., just after the immobilization period and not
during the immobilization period per se). Such a progressive
restoration of protein synthesis sensitivity to leucine was shown
during the recovery period in other catabolic situations as
glucocorticoids [28] and considering the anabolic effect of
leucine supplementation on protein synthesis rates in our
model, a similar mechanism of restoration of sensitivity of
protein metabolism to leucine can be hypothesized.
To summarize, we demonstrated in this study that a dietary
supplementation of antioxidants/polyphenols and leucine can
accelerate the recovery of muscle mass in casted adult rats.
This quicker recovery was explained by an increased activation
of protein synthesis rates both in the post prandial and the post
absorptive states over the entire recovery period in the
supplemented animals. Such nutritional strategies can hence
be valuable alternative/additional means to favour recovery
after disuse for patients unable to perform physical exercise
during recovery in adults. More generally, there are a number
of clinical pathologies associated with dramatic muscle atrophy
and catabolic state. The reasons for this atrophy are from
various origins but bed rest is partially responsible for this
condition. Thus, the benefit of antioxidant/polyphenols and
leucine supplementation observed in the present study could
open new nutritional therapies for recovery period of such
catabolic patients. The next step will be to validate the
utilization of this combination of antioxidants and leucine in
humans during and after bed rest.
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